Cynosure (CYNO) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Cynosure (CYNO) PT Bumped to $45 at Leerink Partners
July 29, 2015 9:34 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and lifted his price target on Cynosure (NASDAQ: CYNO) to $45.00 (from $42.00) after updating its model following Q2 results.
Newitter commented, "We update our model to reflect: (a) 2Q results, (b) a slightly more... More
Weakness in Cynosure (CYNO) Following Results Creates Buying Opportunity, Leerink Partners Says
July 28, 2015 10:02 AM EDTLeerink Partners analyst Richard Newitter said the 5% sell-off in Cynosure (NASDAQ: CYNO) post earnings is overdone and creates a buying opportunity. The firm reiterated an Outperform rating.
Newitter commented, "CYNO Shares are off ~5-10% in early morning trading likely in... More
